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Obesity is known to be associated with increased risk in various cancer types. Several 
biological mechanisms underlying this association have been proposed, including alterations 
in sex hormone metabolism, insulin and insulin-like growth factor signaling, and adipokines 
and the inflammatory system, but there are limitations to all these previously proposed 
mechanisms. We explore a new explanation for the association, that is, individuals with 
higher BMIs have larger organs, which consist of more cells that are at risk of becoming 
cancerous. We search through literature to find studies on the association between BMI or 
body weight and organ size. We find that for cancers originating in the gallbladder, thyroid, 
liver, kidney, pancreas, and gastric cardia, the estimated relative increases in organ sizes due 
to obesity are comparable to the relative increases in risk of cancer due to obesity reported by 
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1.1 Obesity  
Overweight and obesity are conditions characterized by excess body fat. The body 
mass index (BMI) is commonly used to screen for overweight or obesity. Though not a direct 
measurement of body fat, BMI has been shown to be moderately correlated with more direct 
measures of body fat obtained from skinfold thickness measurements and dual X-ray 
absorptiometry (Wohlfahrt-Veje et al. 2014). BMI is calculated as weight in kilograms divided by 
square of height in meters. A BMI of 18.5-24.9 is considered normal, 25.0-29.9 overweight, 
and >30.0 obese. Obesity can be further classified into class 1 (BMI 30.0-34.9), class 2 (BMI 
35.0-39.9) and class 3 (BMI > 40.0). 
Obesity has risen to a major global public health challenge. The worldwide obesity 
prevalence has nearly tripled since 1975, with around 13% of the world’s adult population 
being obese and 39% being overweight in 2016 (WHO 2020). Despite the noticeable 
increasing trends, no nation has been successful in reducing its obesity rate in the 33 years 
from 1980 to 2013 (Ng et al. 2014).  
1.2 Obesity and Cancer Risk 
Obesity is known to increase risks of diseases including cardiovascular diseases, type 
2 diabetes, and certain types of cancer. The International Agency for Research on Cancer 
(IARC) Handbook Working Group has found sufficient evidence that overweight and obesity 
lead to significantly increased risk in cancer in 13 organs: esophagus (adenocarcinoma), 
gastric cardia, colon and rectum, liver, gallbladder, pancreas, breast (postmenopausal), corpus 
uteri, ovary, kidney (renal cell), meningioma, thyroid and multiple myeloma (Lauby-Secretan 
et al. 2016).  
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Several biological mechanisms underlying the association between obesity and 
increased cancer risk have been proposed, including alterations in sex hormone metabolism, 
insulin and insulin-like growth factor (IGF) signaling, and adipokines and the inflammatory 
system (Renehan et al. 2015). However, these hypotheses all have caveats, and the true 
mechanisms underlying the increased cancer risk have yet to be fully uncovered. 
Here, we propose a new possible mechanism: individuals with higher BMIs have 

















We were interested in how organ sizes of individuals with BMIs of 30, 35, 40, 45, and 
50 compared to organ sizes of individuals with a lean BMI of 22. To investigate the 
relationship between BMI and sizes of various organs, we searched through literature. 
Though studies have been done on individuals with BMIs falling in the overweight and obese 
range, cases beyond class 1 obesity (BMI 30.0-34.9) have rarely been considered. Thus, we 
used linear extrapolations to extend the analysis to a full range of BMI values. Steps taken in 
the analysis of seven cancer sites (gallbladder, thyroid, liver, kidney, pancreas, gastric cardia, 
and corpus uteri) are further detailed below. 
2.1 Gallbladder 
Stone et al. studied gallbladder function in healthy, gallstone-free individuals (Stone 
et al. 1992). Seven subjects with normal BMI (BMI < 25.5) and seven subjects with high 
BMI (BMI > 33) were recruited. Subjects were given liquid emptying stimuli to produce 
maximal gallbladder emptying, and their gallbladder volumes were measured every 20 
minutes during a 2-hour period. The serial measurements were made by scanning with an 
ATL Ultrasound System which produced longitudinal and transverse images from which 
length and diameter measurements at 1-cm intervals were attained and used to calculate 
volume by the sum-of-cylinders technique. Residual volume was then taken as the minimal 
gallbladder volume recorded during the 2-hour period. 
Subjects in the normal BMI group (22 ± 1) had an average gallbladder residual 
volume of 4.2 (± 1.3) ml compared to 8.4 (± 2.3) ml in the high BMI group (36 ± 1). 
Assuming a linear relationship between BMI and gallbladder residual volume, this translates 
into a 0.3 ml increase per BMI unit.  
Since nearly all gallbladder cancers begin in glandular cells that line the inner surface 
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of the gallbladder, we are interested in comparing the inner surface areas of the organ 
corresponding to different BMIs. We only had data for the relationship between BMI and 
gallbladder residual volume though, so we computed gallbladder volumes corresponding to 
different BMIs and then estimated inner surface areas corresponding to different volumes of 
the gallbladder. More specifically, literature shows a normal gallbladder measures around 7-
10 cm in length and 2-3.5 cm in diameter with a wall thickness of 2-3 mm (Bisset et al. 
2008). We took the midpoints of these measurements and approximated the gallbladder as a 
spheroid, assuming that the relative proportions of the organ measurements stay the same 
with increases in organ size (Supp. Figure 1).  
2.2 Thyroid 
Sahin et al. studied sizes of thyroid glands in Turkish Adults (Şahin et al. 2015). The 
study enrolled 292 females and 169 males, ranging from 18 to 61 years of age, all of whom 
had normally functioning thyroid glands. The Logiq 5 Pro ultrasound machine was used to 
scan images of each thyroid lobe. Craniocaudal and sagittal measurements were attained from 
the longitudinal image, and the transverse measurement was obtained from the transverse 
image. The ellipsoid formula was then used to estimate the volume of each lobe. 
In males, regression of total thyroid volume in mL (y) on weight in kg (x) gave rise to 
the equation:  
y = 0.1433x + 2.9141. 
In females, the linear regression equation was:  
y = 0.1019x + 5.1557. 
The range of weights in females was ~45 kg to ~100 kg, and in males ~60 kg to ~ 110 kg. We 
are interested in the relationship between thyroid size and BMI rather than weight but it is 
easy to link these two together as BMI is calculated as weight (in kilograms) divided by 
height (in meters) squared. Height was held constant at the average height in the U.S., which 
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is 176.0 cm for men and 161.9 cm for women, while weights corresponding to different BMI 
values were recorded and used to estimate respective thyroid volumes.  
2.3 Liver 
In a study by Gallagher et al., overweight and obese adults (BMI 25 to <41) with type 
2 diabetes were enrolled in a diet and exercise weight-loss intervention program, and changes 
in various organ sizes (skeletal muscle, heart, liver, kidney, spleen, and pancreas) after the 
intervention were measured (Gallagher et al. 2017). MRI scans with 5-mm slice thickness 
were acquired and analyzed to obtain volume estimates, which were then converted to mass 
estimates by assuming a 1.04 kg/L density for the liver. 
At the study baseline, the women weighed on average 82 ± 14 kg, and had an average 
liver weight of 1.76 ± 0.50 kg; the men weighed on average 93 ± 8 kg, and had an average 
liver weight of 1.90 ± 0.40 kg. After two years of weight-loss intervention, the subjects 
weighed on average 5.21 ± 0.74 kg less while MRI-derived measurements showed that their 
liver weighed 0.11 ± 0.03 kg less. This suggests a 0.02 kg decrease in liver weight per 1 kg 
decrease in body weight.  
Again, to get measurements in terms of BMI, height was held constant at the average 
U.S. height while weights corresponding to different BMI values were recorded and used to 
estimate respective liver masses. Since mass is proportional to volume, the ratios of liver 
masses corresponding to different BMI values are equal to the ratios of liver volumes 
corresponding to different BMI values. 
2.4 Kidney: Renal-cell 
The most common type of kidney cancer is renal cell carcinoma, which originates in 
the lining of the proximal convoluted tubule. No information regarding effects of obesity on 
the dimensions of the proximal tubule could be found, so instead, here we assume that the 
surface area of the proximal tubule increases proportionally with kidney volume.  
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In the same study mentioned above, Gallagher et al. also investigated changes in 
kidney size as a result of weight loss (Gallagher et al. 2017). At the study baseline, the 
women weighed on average 82 ± 14 kg, and had an average kidney weight of 0.38 ± 0.11 kg; 
the men weighed on average 93 ± 8 kg, and had an average kidney weight of 0.46 ± 0.08 kg. 
After two years of weight-loss intervention, the subjects weighed on average 5.21 ± 0.74 kg 
less while MRI-derived measurements showed that their kidney weighed 0.02 kg less. This 
suggests a 0.0038 kg decrease in kidney weight per 1 kg decrease in body weight. The ratios 
of kidney volumes corresponding to different BMI values were obtained using the same 
methods as for the liver calculations described above. 
2.5 Pancreas 
Saisho et al. studied the effect of gender, obesity and type-2 diabetes on pancreas 
volumes (Saisho et al. 2007). The study enrolled 997 females and 724 males (1721 total) over 
the age of 20, all of whom had normally functioning pancreata. Whole-body CT scans of 
subjects were acquired. Fat was differentiated from parenchymal tissue based on the 
differential density of the two types of cells. Total parenchymal volume of the pancreas was 
calculated as the sum of volumes from each CT section, which was obtained by multiplying 
parenchymal area in a CT slice (pixel area in cm2) by the CT slice thickness. The regression 
equation relating parenchymal pancreas volume in cm3 (y) to BMI (x) was given as: 
y = 34.6 + 0.55x. 
2.6 Gastric Cardia 
The stomach has five main regions, the cardia, the fundus, the body, the antrum, and 
the pylorus. No studies were found that specifically address the size of the gastric cardia in 
relation to BMI, so we assumed that the proportions of the regions of the stomach remain 
fixed. In other words, the size of the cardia increases proportionally with the size of the 
whole stomach.  
 7 
Geliebter measured gastric capacity in four lean and four obese subjects (Geliebter 
1988). A latex gastric balloon was inserted into the stomach and after each inflation of 100 
ml, subjects would rate their discomfort on a scale from 1 (none) to 10 (extreme). Stomach 
capacity was characterized as the volume of the gastric balloon when the subject reported a 
discomfort of 10. The mean gastric capacity for lean subjects (mean BMI = 22.3) was 1100 
ml, and for obese subjects (mean BMI = 31.5) was 1925 ml. This translates into a 90 ml 
increase per BMI unit.  
Almost all stomach cancers are adenocarcinomas, which develop from cells that line 
the inside of the stomach. To compute surface area, the stomach is approximated as a 
spheroid. The average-sized human stomach has a greater curvature that measures at 26-31 
cm (Ferrua & Singh 2011). The average volume of the stomach is 0.94 L, and using 28.5 cm 
as the major axis length (midpoint of the greater curvature reported above), the minor axis 
length is derived to be approximately 8 cm. These measurements allow us to define the shape 
of the stomach and thus estimate its surface area given its volume (Supp. Figure 2). 
2.7 Corpus Uteri  
Parmar et al. studied uterine dimensions in 80 women (40 parous and 40 nulliparous) 
(Parmar et al. 2016). Study participants excluded those who were pregnant, in menstrual 
cycle or had a pathological uterus. Measurements of uterine length, width and wall thickness 
were obtained with high resolution ultrasonography. 
The mean uterine length of parous women was 8.63 cm for those with a body weight 
51-60 kg, and 9.06 cm for those with a body weight 61-70 kg. In nulliparous women, mean 
uterine length was 7.08 cm for those with a body weight 51-60 kg, and 7.45 cm for those with 
a body weight 61-70 kg. This translates into an increase in uterine length of 0.43 cm in 
parous women, and 0.37 cm in nulliparous women per 10 kg increase in body weight. 
According to the U.S. Census Bureau's Current Population Survey in 2018, 49.8 percent of women 
 8 
aged 15 to 44 had never had children (U.S. Census Bureau 2018). Taking this into account, the 
weighted increase in uterine length is 0.40 cm per 10 kg increase in weight.  
Parmar et al. only reported the correlation between uterine length and body weight but 
not other dimensions of the uterus. We chose to approximate the corpus part of the uterus as a 
cone, where the ratio of the length to base diameter of the cavity of body of the uterus was 
taken to be 1.9 (Umar et al. 2017), and assumed that base diameter increases proportionally 
with length as body weight increases (Supp. Figure 3). Again, to get measurements in terms 
of BMI, height was held constant at the average U.S. height while weights corresponding to 















Our estimates of increases in organ size when going from normal weight (BMI=22) to 
extreme obesity (BMI=50) are provided in Table 1. The gallbladder, liver, and gastric cardia 
are estimated to more than double in size for extremely obese individuals, while other organs 
are expected to undergo a smaller increase in size. The estimated relative increases in organ 
sizes due to obesity are comparable to the relative increases in risk of cancer due to obesity in 
all cancer types except for corpus uteri. 
 
Table 1: Extrapolated relationship between BMI and organ size, and increase in cancer risk  
Cancer type Gender Relative Organ Size of BMI Categories 













Gallbladder Combined 1.35 1.55 1.74 1.91 2.08 1.3 (1.2-1.4) 
Thyroid M 1.28 1.46 1.63 1.81 1.98 1.1 (1.0-1.1) 
 F 1.19 1.31 1.44 1.56 1.68  
Liver M 1.38 1.62 1.86 2.09 2.33 1.8 (1.6-2.1) 
 F 1.36 1.58 1.80 2.02 2.24  
Kidney:  M 1.26 1.42 1.59 1.75 1.91 1.8 (1.7-1.9) 
renal-cell F 1.28 1.46 1.63 1.81 1.98  
Pancreas Combined 1.09 1.15 1.21 1.27 1.33 1.5 (1.2-1.8) 
Gastric 
cardia 
Combined 1.41 1.63 1.84 2.04 2.23 1.8 (1.3-2.5) 
Corpus uteri F 1.20 1.33 1.47 1.62 1.77 7.1 (6.3-8.1) 
* Relative risk of highest BMI category (BMI ≥ 40.0) evaluated versus normal BMI (18.5-
















Our findings suggest that obesity may induce an increase in the number of cells 
forming an organ and thus an increase in risk of cancer originating from that organ. This 
mechanism appears sufficient to explain the increase in cancer risk in the gallbladder, 
thyroid, liver, kidney, pancreas, and gastric cardia linked to extreme obesity, but not the 
massive increase in cancer risk in the corpus uteri, suggesting that other factors may be at 
play in uterine cancer in the obese. To further validate our findings, our analyses could be 
extended to other organs for which there is sufficient evidence of an increase in cancer risk as 
a result of excess body fat as reported by IARC.  
In analyzing the pancreas, we considered only parenchymal tissue as we were able to 
find a study that separated parenchymal tissue from fat. We weren’t able to find such 
information for other organs, so our estimates of organ size ratios may be larger than if the 
estimates were based only on non-fat tissue. However, most estimates should be unaffected 
since adipose tissue is not commonly found in most organs. Ectopic fat could though 
accumulate in some organs such as the liver or kidney, but the fat content does not differ 
greatly between healthy and obese individuals. Specifically, comparing obese to normal 
weight individuals, the median fat content in the liver is 4.57% vs 1.11%, and in the kidney 
1.35% vs 0.64% (Sijens et al. 2010). Thus, the larger liver and kidney volumes measured in 
obese individuals are a result of an increase in parenchymal and not fat cells. 
Our analyses were based on literature search performed to understand how organ 
dimensions are associated with BMI or body weight. Such studies were scarce and use of 
information from these studies lead to limitations in our results. Studies often involved 
subjects with BMIs that did not cover the full range of BMI values we were interested in 
(BMI 22-50). In the Gallagher study from which data on liver and kidney size were used, 
subjects had BMI values up to only 41. In the study on stomach size, subjects had BMI 
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values up to only 35, and in the uterus study, women weighed only up to 70 kg. Thus, our 
analysis was based on extrapolations in which we were making estimations of organ sizes 
associated with extreme BMI values that were beyond the original observation range. That is, 
we were assuming that the trends of increasing organ sizes found in ranges of lower BMI 
values would extend to ranges of higher BMI values. To validate whether our assumptions 
are acceptable, we would need data across a full range of BMI.  
Other limitations of some studies include small sample size, with the gallbladder 
study having enrolled 14 subjects and the gastric capacity study having enrolled only 8. In 
addition, the gastric capacity study measured capacity in intervals of 100 ml, so 
measurements obtained were not precise, and maximum capacity was based on subject 
reporting of extreme discomfort, which different individuals may have different tolerance of. 
Both the gallbladder study and the gastric capacity study were conducted over 20 years ago, 
so a more recent study enrolling a larger set of individuals and using more advanced 
measurement technology would be needed to consolidate these findings. However, the 
gallbladder and stomach, being hollow organs, may undergo changes in size due to oral 
intake and thus accurate measurements may be hard to obtain, which could explain why data 
on these two organs were scarce, which led us to using studies that had evident limitations. 
 The IARC working group reported relative risks for gastric cardia cancer and renal 
cell cancer, but we could not find information on the size of the cardia or the proximal 
convoluted tubule in relation to BMI, so increases in size of the entire stomach and kidney 
were used, and it was assumed that all parts of an organ increase proportionally with 
increasing BMI.  
 Most studies we found compared organ sizes between a healthy group and an 
overweight or obese group, or reported on values of organ sizes across a range of BMI. The 
Gallagher study, though, compared organ sizes in the same set of subjects, before and after 
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weight loss. It will be interesting, in the future, to study whether weight loss can lead to 
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Maryland School of Medicine, Department of Neurosurgery 
•  Developed a systematic method to generate reliable results with the CatWalk gait 
analysis tool, which was used to explore the viability of novel methodologies in 
promoting nerve regeneration after peripheral nerve injury  
•  Analyzed EEG recordings using MATLAB to assess the effects of therapeutic 
hypothermia on neurological recovery outcomes from cardiac arrest 
 
High School Research Assistant                                                         June-August 2012    
Yale School of Medicine, Neurology Department 
•  Explored the role of a number of intrinsic sequence motifs in targeting prestin to the 
lateral wall of outer hair cells (OHCs), a process critical for cochlear amplification 
 
TEACHING EXPERIENCE  
 
Teaching Assistant                                               September 2019-Present 
Statistical Methods in Public Health series (450 graduate students), Johns Hopkins 
Bloomberg School of Public Health, Department of Biostatistics 
 
Teaching Assistant                                                                September-December 2016 
Systems Bioengineering III (140 undergraduate and graduate students), Johns Hopkins 
University, Department of Biomedical Engineering 
 
Tutor                                                                             September 2014-December 2015     
Johns Hopkins Learning Den 
 •  Led small group tutoring sessions for a wide range of courses including Biology, 
Calculus, Differential Equations, Intro Programming in Java, Models & Simulations, 
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Technical: R, Python, MATLAB, SAS, Java 
Languages: Chinese (Native), French (Elementary proficiency)  
 
